Claus Cursiefen

Papers

Total Citations

H-Index

About

Claus Cursiefen is a leading figure in ophthalmology, renowned for his pioneering work in corneal and ocular surface diseases, as well as innovative approaches to ocular oncology. His research has fundamentally advanced the understanding of corneal neovascularization, lymphangiogenesis, and immune privilege, translating these insights into novel therapeutic strategies for conditions like dry eye disease and corneal graft rejection. Among his most notable contributions is the exploration of CyberKnife® radiosurgery as a precise, non-invasive treatment for uveal melanoma, a life-threatening intraocular tumor. This work, detailed in his highly cited 2017 paper, has opened new therapeutic avenues, offering patients a targeted alternative to traditional enucleation or plaque brachytherapy. With over 12,000 citations across his career, Cursiefen’s impact is profound, shaping both clinical practice and basic science. He has also been instrumental in developing anti-angiogenic therapies and has received numerous awards for his translational research, solidifying his reputation as a visionary whose work bridges molecular mechanisms and patient care.